Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine.
We describe a new monoclonal antibody (designated Bu20a) against bromodeoxyuridine (BrdU). This antibody was selected by screening against human tissues using the APAAP technique, and shows no crossreactivity with normal nuclei. It stains BrdU incorporated into the nuclei of a wide range of cell types, including human tonsil lymphoid cells, normal mouse tissues, and human tumors growing in nude mice. A double-labeling technique is described using this antibody in which cell smears or tissue sections are first labeled by an immunoperoxidase procedure for a cellular antigen (e.g., mouse or human histocompatibility class II antigen, T-lymphocyte antigen, keratin) and BrdU is then detected by indirect immunofluorescence. This procedure, which was applied to a variety of human and animal cells and tissues, is of wide potential value in analyzing the phenotype of S-phase cells and in co-localizing antigen expression and BrdU incorporation in tissue sections.
Magaud
J P
JP
Nuffield Department of Pathology, John Radcliffe Hospital, Oxford, United Kingdom.
Sargent
I
I
Clarke
P J
PJ
Ffrench
M
M
Rimokh
R
R
Mason
D Y
DY
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D001973:Bromodeoxyuridine / Q000032:analysis / Q000276:immunology* / Q000378:metabolism; D002467:Cell Nucleus / Q000032:analysis*; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D007124:Immunoenzyme Techniques; D007150:Immunohistochemistry; D007399:Interphase; D007633:Keratins / Q000032:analysis; D008221:Lymphoid Tissue / Q000032:analysis; D009369:Neoplasms / Q000032:analysis; D051381:Rats; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000949:Histocompatibility Antigens Class II; D007633:Keratins; D001973:Bromodeoxyuridine